Table 3

Summary of the clinical pathological status of TNBC and non-TNBC used for EGFR, CK5/6 and c-KIT immunohistochemical analysis
Characteristic No. of patients (%)
TNBC (N = 18) non-TNBC (N = 18)
AGE AT DIAGNOSIS (y)
  ≤ 40 3 (16.6%) 2 (11.1%)
  41 ≤ y ≤ 49 10 (55.5%) 7 (38.9%)
  50 ≤ y ≤ 65 5 (27.7%) 6 (33.3%)
  > 65 0 (0.0%) 3 (16.7%)
GRADE
  1 (well differentiated) 0 (0%) 0 (0%)
  2 (moderately differentiated) 3 (16.6%) 5 (27.8%)
  3 (poorly differentiated) 15 (83.3%) 13 (72.2%)
TUMOR SIZE (cm)
  ≤ 2 7 (38.9%) 5 (27.8%)
  2 < cm ≤ 5 5 (27.8%) 9 (50.0%)
  > 5 3 (16.7%) 1 (5.6%)
  Unknown 3 (16.7%) 3 (16.7%)
LYMPH NODE INFILTRATION
  Positive 4 (21.1%) 8 (44.4%)
  Negative 14 (77.8%) 10 (55.6%)

Note: Percentage (%) indicates the percentage within the subgroup.

Kanapathy Pillai et al.

Kanapathy Pillai et al. BMC Clinical Pathology 2012 12:18   doi:10.1186/1472-6890-12-18

Open Data